Jun 17, 2019 / 01:00PM GMT
Operator
Welcome to the Mesoblast Virtual KOL Symposium Conference Call. My name is Sylvia, and I'll be the operator for today's call. (Operator Instructions) I will now turn the call over to Josh Muntner, CFO of Mesoblast. Mr. Muntner, you may begin.
Josh Muntner - Mesoblast Limited - CFO
Thank you. And thanks for joining the call today. I'm Josh Muntner, the Chief Financial Officer of Mesoblast. And just want to remind everyone that we will be making some forward-looking statements on this call today, and that it's proper to review our full disclosures on our website and our filings with the ASX and the SEC.
The primary goal of today's call is to provide a deeper dive on our most advanced program, remestemcel-L, for the treatment of steroid-refractory acute Graft Versus Host Disease, for which we have begun enrolling BLA submission to the U.S. FDA. We envision today's call as an opportunity for a deeper discussion of this therapeutic indication as well as our product and commercial plans. We're joined today by Dr. Susan Prockop, a pediatric hematologist
Mesoblast Ltd Virtual KOL Symposium Transcript
Jun 17, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers